Ratings NEURONES

Equities

NRO

FR0004050250

Market Closed - Euronext Paris 11:35:00 2024-04-26 am EDT 5-day change 1st Jan Change
44.7 EUR -0.45% Intraday chart for NEURONES -4.39% +2.17%

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • With a 2023 P/E ratio at 21.57 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
  • In relation to the value of its tangible assets, the company's valuation appears relatively high.
  • The average consensus view of analysts covering the stock has deteriorated over the past four months.

Ratings chart - Surperformance

Sector: IT Services & Consulting

1st Jan change Capi. Investor Rating ESG Refinitiv
+2.17% 1.17B -
-12.23% 194B
A-
+0.74% 167B
B+
+2.19% 155B
B-
+4.34% 101B
A-
+7.04% 76.69B
A-
+19.09% 72.08B
C-
-7.30% 71.48B
A
-20.54% 50.93B
C
+0.53% 48.89B
A-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes